denovoSkin (c) Frank Brüderli

A tissue therapeutics revolution

CUTISS is the only late-stage clinical TechBio company developing skin tissue therapeutics and dedicated to bioengineering. We are transforming skin surgery with denovoSkin™, our first-in-class personalized tissue therapy that enables automated, on-demand production of living skin at scale.

The only living, true human skin – on demand

Developed for patients requiring skin surgery – from massive burns to reconstructive and aesthetic applications – denovoSkin™ has shown long-term safety and efficacy compared to the standard of care.

In-house manufacturing

We manufacture denovoSkin™ for clinical use at our state-of-the-art, certified Good Manufacturing Practice (GMP) facility in Zurich, Switzerland.
Play Video

Highly-scalable, automated production

We have developed a first-in-class automation platform for the scalable production of personalized tissue therapy. It is a patented, fully-closed, end-to-end system that enables decentralized production, cost-effective scale-up, and high return on investment.

This pioneering platform allows for expansion across multiple frontiers:

  • In regenerative medicine, enabling the development of next-priority tissues such as gums, cornea, and muscle, making personalized treatments more accessible at the point of care.
  • In Space Health research, accelerating discoveries in healing and ageing.
  • Beyond healthcare, driving the high-scale production of bioengineered tissues for industrial applications.
Scroll to Top

Newsletter

Would you like to contact us as a journalist?

©WyssZurich

This website uses cookies to ensure you get the best experience on our website.